Rodrigo G Salinas

Rheumatology Around the World 🌎 Establishing Centers of Excellence for Axial Spondyloarthritis in Latin America: Consensus Recommendations From the REAL-PANLAR Group 📖 doi.org/10.3899/jrheum… @RodrigoGSalinas @italianolaplata @PedroSantosMor5 @BiomabAR #Spondyloarthritis

It was a true honor to participate as a speaker at the @PPACMANgroup meeting in New York 🗽 , sharing our experience in the diagnosis and comprehensive evaluation of patients with psoriatic arthritis (#PsA).

Gracias por compartir x.com/jrheum/status/…

NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @PanlarLeague Free to read with registration on lancet.com

Proud to share our new paper on the pre-RA stage just published @seminarthrheum 📄 “Progression from seropositive arthralgia to rheumatoid arthritis: One-year predictors from a large cohort in the Reuma-Check program.”

Honored to share that I’ve been invited as a speaker at the 9th PPACMAN Annual Meeting in New York City on December 18, 2025 🗽 👉 “Arthralgia with Risk of Progression to Psoriatic Arthritis: Lessons from Reuma-Check” @PPACMANgroup #PsA

An Honor be part @PanlarLeague

Thank you was an a real team work, @jrheum

@psoriasis_hub Thank you

CONGRESS | #ACR25 | PRESENTATION Rodrigo Garcia-Salinas, Hospital Italiano La Plata, discusses findings from a prospective longitudinal cohort study investigating the therapeutic approach in patients with arthralgia at risk of progression to #PsA (ARP-PsA; N = 119). A total of 44% of patients with ARP-PsA initiated treatment with NSAIDs (50%), csDMARD (48%), and corticosteroids (1%). Among these, 36% of patients met at least one high-risk criterion, with 60% receiving csDMARD (p = 0.04). At 1 year, 29% of patients developed PsA, of whom 62% were receiving csDMARD (p = 0.002). Follow our live feed for more updates: loom.ly/HoxlbLs Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website. #Psoriasis #PsoriaticArthritis #MedEd #MedicalCongress #RheumTwitter @italianolaplata

🔬 New study by Dr. Rodrigo García Salinas et al. 💡D2M-#axSpA affects ~ 9% of patients in real-world clinical practice. 🧩Clinical and structural predictors such as psoriasis, smoking and joint damage are associated with D2M. 🧪Articular US is a key tool for identifying high-risk patients. 📖rdcu.be/eB76f

Toward Harmonized Recommendations for Psoriatic Arthritis: A Comparative Viewpoint on Global Guidelines jrheum.org/content/early/…

Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup? 👉rdcu.be/d9uzU 📊 Key findings from the Reuma-check cohort: ✔️ 28% of axSpA cases started at ≥45 years. ✔️ More common in females (51%) & psoriasis (42%). ✔️ Lower NSAID response (52%) & HLA-B27 positivity (32%). ✔️ Shorter diagnosis delay (40 vs. 93 months) than early-onset axSpA ⚠️ lo-axSpA may require distinct diagnostic & treatment approaches. doi.org/10.1007/s10067…

🚀 ¡Un curso imperdible como apertura de PANLAR 2025! El SPARTAN–PANLAR axSpA Pre-congress Educational Course es la mejor manera de iniciar el evento reumatológico del año. 👉 Descubre todo lo que necesitas saber deslizando y prepárate para una experiencia educativa única. 🔥 ¿Qué tan desafiante crees que será este taller? Cuéntanos en los comentarios cuántos 🌶 le das y asegura tu lugar en este imperdible curso. 🌟 ¡Reserva tu cupo ahora y sé parte de PANLAR 2025! congreso-panlar.com/trabajos-cient… . #PANLAR2025 #YoVoyAPANLAR

@reumacia Bocadillo de Calamar…. Y unas pintas.

Empieza el fin de semana 🍻

✅ Queremos compartir la noticia del registro #ESPALDA. Contamos con información de más de 400 pacientes con #Espondiloartrtitis Axial ✅Datos de países de #AmericaLatina para generar datos en la región Gracias a investigadores locales @PanlarLeague @RodrigoGSalinas @FerSommer

@mariaj_morenom @GRESSER_Espa @SEReumatologia @SMurcianaReuma Las menos son por axSpA,

No todas las alteraciones en las scroiliacas es por #Espondiloartritis @GRESSER_Espa @SEReumatologia @SMurcianaReuma Con permiso #ReumaImagen

@reumacia Podemos usarla para cuando visitamos la hermosa Madrid

Mi padre dejó pendientes de visitar unos 40 sitios de Madrid con especialidades de la casa para probar. Ayer empezamos el periplo de visitarlos todos en su honor y recuerdo 🌹🌹 Primera parada: Casa Revuelta.

Un gran equipo de expertos, apasionados reumatólogos reportando para @reumatimes en el American College of Rheumatology 2024 #ACR2024 #reumatimes

Es un orgullo y un placer anunciar para toda América el “SPARTAN-PANLAR axSpA pre-Congress educational course” una iniciativa de @PanlarLeague y @SPARTAN_Updates